ChronoScale Corporation Common Stock (NASDAQ:CHRN) Shares Climb 9.6% – Here’s What Happened

ChronoScale Corporation Common Stock (NASDAQ:CHRN) shot up 9.6% during mid-day trading on Tuesday. The stock traded as high as $16.08 and last traded at $16.04. Approximately 38,266 shares changed hands during trading, a decline of 83% from the average session volume of 223,190 shares. The stock had previously closed at $14.63.

Wall Street Analysts Forecast Growth

Several analysts have commented on CHRN shares. Compass Point started coverage on shares of ChronoScale Corporation Common Stock in a report on Friday, October 16th. They issued a “buy” rating and a $25.00 price objective for the company. Weiss Ratings lowered ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a research report on Friday. Finally, Northland Securities began coverage on ChronoScale Corporation Common Stock in a research note on Friday, September 18th. They issued an “outperform” rating and a $32.00 target price for the company. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $21.00.

ChronoScale Corporation Common Stock Stock Up 16.0%

The company has a quick ratio of 0.30, a current ratio of 0.30 and a debt-to-equity ratio of 0.02. The company’s fifty day moving average price is $19.20 and its 200-day moving average price is $15.81. The stock has a market capitalization of $2.47 billion, a PE ratio of -3.93 and a beta of 0.98.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its earnings results on Wednesday, October 14th. The company reported ($0.29) EPS for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 66.16% and a negative net margin of 135.66%. The company had revenue of $41.48 million during the quarter. Analysts forecast that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.